New drug - Relistor
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Although the final extended hours directed enhanced service (DES) has yet to be published, the DoH h... Read more
Polyclinics are either the panacea to the NHS's ills or a threat to the very future of primary care,... Read more
Last week the government announced it is to hold a six-month debate on the future of care and suppor... Read more
What a difference two years can make. In 2006, the then health secretary Patricia Hewitt was forced ... Read more
Last month it was announced that one of the final barriers to nurse prescribing is to be scrapped (I... Read more
Recent years have seen huge changes in the way many NHS services are delivered, but it seems that th... Read more
The DoH set out its vision of an expanded role for primary care nurses in 2002's Liberating the Tale... Read more
At the time of writing it seems that GPs will vote to accept the revised extended hours directed enh... Read more
During the next fortnight the consultations on the future of pre- and post-registration education wi... Read more
News that the Scottish government is pushing ahead with plans to reform community nursing has caused... Read more
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more